Li Zhuang

机构：Hubei University of Chinese Medicine, Dongguan People’s Hospital, National Institutes for Food and Drug Control, Zhejiang University · ORCID：0000-0001-9056-7681

发表论文 150 篇 · 总被引 13489 次 · h-index 38

代表论文

• Interleukin-12 Delivery Strategies and Advances in Tumor Immunotherapy (2024 · Current Issues in Molecular Biology · 被引 32)
• Gut-microbiota-derived indole sulfate promotes heart failure in chronic kidney disease (2025 · Cell Host & Microbe · 被引 29)
• Cuproptosis in cancer: from molecular mechanisms to therapeutic intervention (2025 · Trends in cancer · 被引 13)
• Clinical outcomes and pharmacokinetics/pharmacodynamics of intravenous polymyxin B treatment for various site carbapenem-resistant gram-negative bacterial infections: a prospective observational multicenter study (2025 · Antimicrobial Agents and Chemotherapy · 被引 10)
• Development and validation of a novel prognostic model to predict 1-year post-transplant mortality for acute-on-chronic hepatitis B liver failure: a nationwide, multicentre, cohort study (2025 · EClinicalMedicine · 被引 9)
• Application and new findings of scRNA-seq and ST-seq in prostate cancer (2024 · Cell Regeneration · 被引 9)